QR-Code

Tolerability of switch from erenumab to fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, real-world, observational study

Abstract Objective While erenumab and fremanezumab are effective treatments for migraine prevention, it is unclear whether patients who experience adverse events related to erenumab can tolerate fremanezumab. This study evaluated the tolerability of switching from erenumab to fremanezumab in patient...

Ausführliche Beschreibung

Gespeichert in:
Bibliografische Detailangaben
Hauptverfasser: Faisal Mohammad Amin, Thor Linnet, Christopher Kjaer Cullum, Thien Phu Do, Samaira Younis
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMC 2025-07-01
Schriftenreihe:The Journal of Headache and Pain
Schlagworte:
Online-Zugang:https://doi.org/10.1186/s10194-025-02087-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!